share_log

HC Wainwright & Co. Reinstates Buy on Aldeyra Therapeutics, Announces $10 Price Target

Moomoo 24/7 ·  Apr 2 08:43

HC Wainwright & Co. analyst Matthew Caufield reinstates Aldeyra Therapeutics (NASDAQ:ALDX) with a Buy and announces $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment